Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance
Authors:
- Faranak SharifiFSFaranak Sharifi
- Sahar MazloomiSMSahar Mazloomi
- Reza HajihosseiniRHReza Hajihosseini
- Saideh MazloomzadehSMSaideh Mazloomzadeh
- 26 May 2011
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 28 (1) , 7-11
Abstract
Objective. It has been revealed that low serum magnesium (Mg) is often associated with insulin resistance (IR), cardiovascular problems, diabetes mellitus, and hypertension. Patients with polycystic ovary syndrome (PCOS) are known to have a high incidence of insulin resistance. This study was designed to determine whether women with PCOS exhibit serum magnesium deficiency and its potential association with IR. Subjects and methods. In this cross-sectional study, 103 cases with PCOS and 103 normal women who were matched for their age and body mass index (BMI) were included. Blood samples were collected after an overnight fast and concentrations of calcium, magnesium, testosterone, dehydroepianderosterone sulfate, insulin, fasting plasma glucose (FPG), triglyceride, total cholesterol, and HDL-cholesterol were measured. Results. The risk of PCOS for subjects with Mg deficiency was 19 times greater than those who had normal serum Mg concentrations (p ≤ 0.0001). No correlation was found between Mg and insulin sensitivity or secretion, FPG, dyslipidemias, and also androgen concentrations. After adjustment for calcium concentration the role of magnesium to predict PCOS attenuated and became non-significant (β:−1.9, p: 0.7). Conclusion. The present study provides the first evidence showing that magnesium deficiency is not associated with IR in PCOS. According the evidences of this study, serum calcium concentration is more potent predictor of PCOS than serum Mg and only calcium, not Mg, is related to insulin resistance in PCOS.Keywords
This publication has 31 references indexed in Scilit:
- Decreased Adiponectin Levels in Polycystic Ovary Syndrome, Independent of Body Mass IndexMetabolic Syndrome and Related Disorders, 2010
- The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose toleranceClinica Chimica Acta, 2006
- PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factorsBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectivesAtherosclerosis, 2006
- Metabolic SyndromeCirculation, 2002
- Serum and Dietary Magnesium and the Risk for Type 2 Diabetes MellitusArchives of internal medicine (1960), 1999
- Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The aric studyJournal of Clinical Epidemiology, 1995
- Magnesium deficiency produces insulin resistance and increased thromboxane synthesis.Hypertension, 1993
- Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndromeClinical Endocrinology, 1992
- Magnesium and glucose homeostasisDiabetologia, 1990